Innomab is a dynamic high-performing drug-development
team dedicated to bridging the gap between today’s exciting
molecular biology discoveries and patients' need for safer
more effective drugs.   

Founded in 2008 by three San Francisco Bay Area drug
development professionals, Innomab provides consulting
services in support of promising new drug candidate
molecules from the late stages of laboratory research
through early human clinical trials, at which point, these
molecules may attract acquisition by large pharmaceutical

Consultant Services

Innomab's consultant services are the perfect choice for drug
development.   Whether you are a research organization that
has one or more molecules ready to enter development, or a
development organization that needs consultants to
supplement your capacity, fill specific-skill-set gaps, or extend
your geographic range, let Innomab act as your in-house
development team.

Innomab has also worked with venture capital firms to identify,
evaluate and perform due diligence on new opportunities.

Currently,  Innomab works with several domestic and
international biotechnology companies to provide:

  • Global Project Management for a novel antibody about
    to enter oncology development
  • new product planning for an NCE in early research
  • strategic input into a new company business plan
  • in-licensing opportunity assessment
  • due diligence review for antibodies and small
    molecules in oncology
  • evaluation of CMO vendors
  • development time line benchmarks (infectious disease)
  • input into clinical development plans and study

For further information on Innomab's consultant services,
click on link below for the "Contact Us" page so that we may
further assist you.

Contact Us
Home Page
Innomab logo
San Francisco Bay Golden Gate Bridge
Earth seen from space
DNA Molecule
Collaborative Business Professional Handshake